[Beta 2 microglobulin amyloidosis: a new complication of periodical hemodialysis treatment].
1990
E Paganelli, and
M Corradi, and
G Pavesi
Istituto di Clinica Medica e Nefrologia, Università di Parma.
UI
MeSH Term
Description
Entries
D006435
Renal Dialysis
Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000686
Amyloidosis
A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
Amyloidoses
D001613
beta 2-Microglobulin
An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants.
Thymotaxin,beta 2 Microglobulin
D013997
Time Factors
Elements of limited time intervals, contributing to particular results or situations.
January 1994,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,